Live Breaking News & Updates on Clinical Trial Corner

Stay updated with breaking news from Clinical trial corner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Trial Evaluates Reduced Chemo Post-Stem Cell Transplant in Blood Cancers

The first patient has been enrolled in a clinical trial evaluating a reduced dose of post-transplant immunosuppressive chemotherapy cyclophosphamide for patients with blood cancers. ....

United States , Jefferyj Auletta , Rachelj Cook , International Blood , Science University , National Marrow Donor Program , Marrow Transplant Research , Oregon Health , National Marrow Donor , Clinical Trial Corner ,

First Patient Dosed With Novel Combo in Prostate Cancer Trial

Researchers on a phase 1/2 trial provided the first dose of gotistobart plus Pluvicto to a specific patient population with prostate cancer. ....

Richard Wahl , Langone Health , National Cancer Institut , Perlmutter Cancer Center , Society Of Nuclear Medicine , National Cancer , Drug Shortage , Prostate Cancer Treatment Pluvicto Resolved , Nuclear Medicine , Molecular Imaging , Mallinckrodt Institute , Washington University School , Clinical Trial Corner , Prostate Cancer ,

First Patient Dosed in Phase 2 Cancer Vaccine Trial

A phase 2 trial is evaluating ELI-002 7P, a novel cancer vaccine, for the treatment of patients with KRAS-mutant pancreatic cancer. ....

United States , Christopher Haqq , American Society Of Clinical Oncology , Elicio Therapeutics , Nature Medicine , American Society , Clinical Oncology , Gastrointestinal Cancers Symposium , Pancreatic Cancer , Clinical Trial Corner ,

Trial Analyzing MEK Inhibitor Combo for Ovarian Cancer Subset Begins

A treatment combination of avutometinib and defactinib is being evaluated in a new phase 3 trial for patients with low-grade serous ovarian cancer. ....

City Of , United Kingdom , Rachel Grisham , Susana Banerjee , Dan Paterson , Drug Administration , Memorial Sloan Kettering Cancer Center , Institute Of Cancer Research , Verastem Oncology , Royal Marsden , Cancer Research , Accelerated Approval New Drug Application , Breakthrough Therapy Designation , Accelerated Approval , Ovarian Cancer , Gynecologic Cancer , Clinical Trial Corner ,

Novel CAR-T Cell Therapy To Be Studied in Solid Cancers

B42-001, a novel CAR-T cell therapy, will be tested in a phase 1 trial for the treatment of patients with BT-001 positive solid cancers. ....

Farzad Haerizadeh , Laurence Cooper , What Can Patients With Cancer , Executive Chairman , Clinical Trial Corner ,